510(k) Clearance Archives

Seqirus Wins Approval for Flu Vaccine for Adults 65 and Older

510(k) Clearance, Adults, Adults 65 and Older, Approvals, FDA, FDA/Regulatory, First-In-Class, Flu Vaccines, Influenza, Seasonal Influenza, U.S. Centers for Disease Control and Prevention

Seqirus snagged U.S. FDA approval for Fluad Quadrivalent, the first quadrivalent adjuvanted influenza vaccine developed to help protect adults 65 years and older against seasonal influenza.

February 24, 2020/by BioSpace